W
whiskers
This month's JAPMA featured an article, from what I gather after reading it, about using C-reactive protein as a screen for charcot foot. (It was the 1st article that was in the journal so I read it first.)
A few, of about a hundred, questions/comments relating to this "little gem"
1. Charcot has multiple origins and the title accomodates this fact... but the article is clearly about diabetic pts w/ charcot. Uhhh mmm OK I had to figure that out by reading the first couple of paragraphs. Editors?
2. The article mentions C-reactive proteins being measured, but fails to mention what assay they were measured with and at what interval, both of which, from my limited knowledge of medicine (as a D- student) seem quite important when assessing these markers... and were measures taken to adjust normal values to the pt population being considered or is this just read it and weep nite at the hospital??? This is not to mention that CRPs should be assessed, from what I understand, (as a D- student) as a trend and not as a single event. Ie is the trend going up or down over this period of time...
3. What about false positives or even F. negatives??? Are not diabetics are notorious for manifold conditions ranging from atherosclerosis to increased adipose that all increase c-reactive proteins? Was this accounted for and are they really ideal candidates for this type of screening test without substantial room for error. What is the room for error?
4. Patient selection and background information were not given. Smokers?? Obese?? Male/female?? etc
5. 7 patients??????? It's a good start I guess.
My conclusion, will remain mute but I will ask these questions:
If we D- (GPA) docs, and future docs alike, like myself are to use CRPs as a screening test, how is it that we are to reproduce this gem of a study as a guide?
Do we simply take 1 sample, use a divination rod to assess the CRP level and say yup, the CRPs are high, ya got there an N-fection in you foot. And if the CRPs are low on another day and patient using a souped up electric nail grinder to asses the CRPs are we suppose to say, Yup, ya gotchaself chared-coal foot?
Honestly, what is the METHOD and how exactly do we interpret these results from this study?
And I don't want to hear ya got ta look at the other clinical evidence that occupied a nice size of the article... because that is kinda what we do in the first place, isn't it and if someone is proposing another method, shouldn;t they clue us in to the methodology, practicality and what the negatives and positives of the whole thing are?
In my D- opinion I that CRPs are poor choices for use in SCREENING diabetics period. Although I feel that they are useful clinically, I feel that more serious investigation needs to be done before I would think it was a good idea to clarify perameters and assessin interpretation in subset populations such as diabetics. Step right up and get screened for evil CRPs. Yikes.
I am all for big sophisticated sounding studies and mixing key words and trends in medicne together, but....
Anyway, I am now reading something else (Cat in the Hat) and wishing I were a D+ student so I could actually understand what it meant
plus as a D+ student I could finally count as a person; a real human be-an.
A few, of about a hundred, questions/comments relating to this "little gem"
1. Charcot has multiple origins and the title accomodates this fact... but the article is clearly about diabetic pts w/ charcot. Uhhh mmm OK I had to figure that out by reading the first couple of paragraphs. Editors?
2. The article mentions C-reactive proteins being measured, but fails to mention what assay they were measured with and at what interval, both of which, from my limited knowledge of medicine (as a D- student) seem quite important when assessing these markers... and were measures taken to adjust normal values to the pt population being considered or is this just read it and weep nite at the hospital??? This is not to mention that CRPs should be assessed, from what I understand, (as a D- student) as a trend and not as a single event. Ie is the trend going up or down over this period of time...
3. What about false positives or even F. negatives??? Are not diabetics are notorious for manifold conditions ranging from atherosclerosis to increased adipose that all increase c-reactive proteins? Was this accounted for and are they really ideal candidates for this type of screening test without substantial room for error. What is the room for error?
4. Patient selection and background information were not given. Smokers?? Obese?? Male/female?? etc
5. 7 patients??????? It's a good start I guess.
My conclusion, will remain mute but I will ask these questions:
If we D- (GPA) docs, and future docs alike, like myself are to use CRPs as a screening test, how is it that we are to reproduce this gem of a study as a guide?
Do we simply take 1 sample, use a divination rod to assess the CRP level and say yup, the CRPs are high, ya got there an N-fection in you foot. And if the CRPs are low on another day and patient using a souped up electric nail grinder to asses the CRPs are we suppose to say, Yup, ya gotchaself chared-coal foot?
Honestly, what is the METHOD and how exactly do we interpret these results from this study?
And I don't want to hear ya got ta look at the other clinical evidence that occupied a nice size of the article... because that is kinda what we do in the first place, isn't it and if someone is proposing another method, shouldn;t they clue us in to the methodology, practicality and what the negatives and positives of the whole thing are?
In my D- opinion I that CRPs are poor choices for use in SCREENING diabetics period. Although I feel that they are useful clinically, I feel that more serious investigation needs to be done before I would think it was a good idea to clarify perameters and assessin interpretation in subset populations such as diabetics. Step right up and get screened for evil CRPs. Yikes.
I am all for big sophisticated sounding studies and mixing key words and trends in medicne together, but....
Anyway, I am now reading something else (Cat in the Hat) and wishing I were a D+ student so I could actually understand what it meant
plus as a D+ student I could finally count as a person; a real human be-an.